Skip to main content
AURORA CANNABIS INC logo

AURORA CANNABIS INC — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8843 LEI · 549300F6VHCLKCUWDT34 US Manufacturing
Filings indexed 386 across all filing types
Latest filing 2019-06-21 Regulatory Filings
Country CA Canada
Listing US ACB

About AURORA CANNABIS INC

https://www.auroramj.com/

Aurora Cannabis Inc. is a global company engaged in the production, distribution, and sale of cannabis and cannabis-derivative products. The company serves both the medical and adult-use recreational markets. Its product portfolio includes a range of items such as dried cannabis and cannabis oils. Aurora focuses on establishing a leadership position in the global medical cannabis sector, with an emphasis on patient care and education, and is dedicated to providing products to improve consumer well-being.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to SEC rules under the Securities Exchange Act of 1934. It includes a news release dated June 21, 2019, and is signed by the CFO. The document length is only 1579 characters, indicating it is a short filing. Form 6-K filings typically contain current reports or announcements by foreign private issuers and are not full annual or quarterly reports. Given the short length and the nature of the content (a news release), this filing fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. It is not an Annual Report, Interim Report, Earnings Release, or any other specific report type. Therefore, the classification is RNS with high confidence.
2019-06-21 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to SEC rules under the Securities Exchange Act of 1934. It includes a news release exhibit dated May 21, 2019, and is signed by the CFO. The document length is short (1576 characters) and primarily serves as a regulatory filing to submit information to the SEC. It does not contain detailed financial statements or comprehensive report content such as an annual or interim report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories and includes Form 6-K submissions.
2019-05-21 English
FWP
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Aurora Cannabis Announces Financial Results for the Third Quarter of Fiscal 2019' and contains detailed financial and operational results for the third quarter ended March 31, 2019. It includes comprehensive financial metrics such as revenue, EBITDA, production volumes, and management commentary. The presence of detailed financial data and analysis for a fiscal quarter indicates this is a quarterly financial report. The document is about 15,000 characters long, which is consistent with a substantive report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2019-05-15 English
6-K
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Aurora Cannabis Inc., with the SEC. It includes a sales agreement exhibit related to the sale of common shares. Form 6-K is used for current reports by foreign private issuers to disclose material information that is not required to be reported on Form 20-F or 40-F. The content focuses on a financing transaction (sale of common shares) rather than a full financial report or earnings release. The document length is short (1590 characters), and it is a regulatory filing reporting a capital raising event. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-05-15 English
SUPPL
Capital/Financing Update Classification · 100% confidence The document is a Prospectus Supplement filed pursuant to Form F-10 under the Securities Act of 1933, relating to a new issue of common shares by Aurora Cannabis Inc. It details the terms of the offering, the sales agreement, use of proceeds, risk factors, and other related information. It is a detailed offering document used for capital raising purposes, not a financial report, earnings release, or management discussion. The document is not a report publication announcement but the actual prospectus supplement itself. Therefore, it fits the definition of a Capital/Financing Update (CAP).
2019-05-15 English
FORM 6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to SEC rules. It includes exhibits such as condensed consolidated interim financial statements, management discussion and analysis, and certifications by the CEO and CFO. The presence of interim financial statements and MD&A for a period shorter than a full fiscal year indicates this is an interim or quarterly report. The document length is 1857 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2019-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.